myDNA Personalised Medication Report for Test Patient Name: Test Patient DOB: 00/00/0000 Collected: 17/10/2016 Address: 123 Example Street, myDNA ID: 0000 Received: 18/10/2016 Example Suburb, 3000 Pathology No: 00000000 Reported: 25/10/2016 Doctor: Example Doctor Genetic interpretation by: Copy to: Copy Pharmacist Associate Professor Les Sheffield, MB.BS. FRACP Approved Pathology Practitioner 23077 Clinical Notes: Inadequate analgesic effect. Medication side effects: sweating, gastrointestinal upset and muscle pain. myDNA D REPORT SUMMARY CURRENT MEDICATIONS OVERVIEW MEDICATION GENE(S) PRESCRIBING CONSIDERATIONS BASED ON MYDNA TEST codeine / CYP2D6 Major - significant result that may require altering this medication acetaminophen fluvoxamine CYP1A2 Major - significant result that may require altering this medication CYP2D6 simvastatin CYP3A4 Major - significant result that may require altering this medication SLCO181 esomeprazole CYP2C19 Minor - result should be considered as may affect medication response clopidogrel CYP2C19 Usual prescribing considerations apply MEDICATIONS THAT DO NOT HAVE PRESCRIBING CONSIDERATIONS BASED ON myDNA TEST clarithromycin, candesartan LEGEND: Major prescribing considerations Minor prescribing considerations Usual prescribing considerations Detailed pharmacogenomic interpretation and recommendations are provided in the current medications section below. GENETIC TEST RESULTS OVERVIEW GENE GENOTYPE PHENOTYPE GENE GENOTYPE PHENOTYPE CYP2D6 *47*4 Ultrarapid (with inducer Poor CYP1A2 *1F/*1F present) CYP2C19 *1/1 Extensive (normal) CYP3A4 *1/1 Extensive (normal) CYP2C9 Extensive (normal) CYP3A5 *3/3 Poor VKORC1 Highly increased Low Transporter AA SLCO1B1 CC warfarin sensitivity Function Detailed interpretations of genetic test results are provided in the pharmacogenomic interpretation section below. 